GlassScriptPhysician profile
Timothy N Kaiser
NPI 1558457275
$382.79
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $257.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $92.87 | 2019-2020 | |
| Harmony Biosciences LLC | $90.97 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Optinose US, INC. | $56.51 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.93 | 2020 | |
| Eisai INC. | $16.54 | 2020 | |
| Greer Laboratories, INC. | $12.10 | 2020 | |
| Boston Scientific Corporation | $11.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.